Arnold Palmer Hospital for Children
Orlando, Florida, United States
Hospital in Orlando, Florida
92 W Miller St, Orlando, FL 32806
158 Beds
About Arnold Palmer Hospital for Children
Orlando Health Arnold Palmer Hospital for Children is a 158-bed pediatric hospital in Orlando, Florida, United States. Arnold Palmer Hospital is part of Orlando Health, and is supported by the Arnold Palmer Medical Center Foundation.
There are 158 beds in Arnold Palmer Hospital for Children.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
41
Children's Oncology Group
39
Wake Forest University Health Sciences
14
Abbott Medical Devices
6
Shire
4
Celgene
2
Hoffmann-La Roche
2
National Institute of Allergy and Infectious Diseases (NIAID)
2
Pfizer
2
University of South Florida
2
Vertex Pharmaceuticals Incorporated
2
Clinical Trials at Arnold Palmer Hospital for Children
During the past decade, Arnold Palmer Hospital for Children conducted 81 clinical trials. In the 10-year time frame, 81 clinical trials started and 51 clinical trials were completed, i.e. on
average, 63% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 29 clinical trials were completed. i.e. 107.4%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study on the Effect of High-Calorie Infant Formula on Growth and Nutrition in HIV-Infected Infants
2005-09-01
Completed
2,400
A Comparison of Zidovudine Plus Lamivudine Versus ddI Used Alone or in Combination With Zidovudine in HIV-1 Infected Children
Completed
740
Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma
2001-10-18
Active, not recruiting
1,449
Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin Disease
2006-01-02
2030-12-31
Active, not recruiting
188
Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
2005-11-14
Unknown status
1,164
Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer
2006-02-20
2022-09-30
Completed
111
Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
2006-12-26
2022-12-31
Completed
481
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET
2007-03-26
2028-07-30
Active, not recruiting
379
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Arnold Palmer Hospital for Children" #1 sponsor was "National Cancer Institute (NCI)" with 41 trials, followed by "Children's Oncology Group" with 39 trials
sponsored, "Wake Forest University Health Sciences" with 14 trials sponsored, "Abbott Medical Devices" with 6 trials sponsored and "Shire"
with 6 trials sponsored. Other sponsors include 36 different institutions and
companies that sponsored additional 40 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Arnold Palmer Hospital for Children"
#1 collaborator was "National Cancer Institute (NCI)" with 45 trials as a collaborator, "Children's Oncology Group" with 6 trials as a collaborator, "Beat NB Cancer Foundation" with 5 trials as a collaborator, "Children's Hospital Los Angeles" with 5 trials as a collaborator and "Baylor College of Medicine" with 4 trials as a collaborator. Other collaborators include 165 different institutions and companies that were
collaborators in the rest 137 trials.
Clinical Trials Conditions at Arnold Palmer Hospital for Children
According to Clinical.Site data, the most researched conditions in "Arnold Palmer Hospital for Children" are
"Recurrent Neuroblastoma" (17 trials), "Neuroblastoma" (15 trials), "Refractory Neuroblastoma" (15 trials), "Refractory Non-Hodgkin Lymphoma" (14 trials) and "Recurrent Hepatoblastoma" (13 trials). Many other conditions were trialed in "Arnold Palmer Hospital for Children" in a lesser frequency.
Clinical Trials Intervention Types at Arnold Palmer Hospital for Children
Most popular intervention types in "Arnold Palmer Hospital for Children" are "Drug" (110 trials), "Other" (63 trials), "Procedure" (34 trials), "Radiation" (25 trials) and "Biological" (22 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (37 trials), "Cyclophosphamide" (32 trials), "Vincristine Sulfate" (28 trials), "Etoposide" (23 trials) and "Cytarabine" (18 trials). Other intervention names were less common.
Clinical Trials Genders at Arnold Palmer Hospital for Children
The vast majority of trials in "Arnold Palmer Hospital for Children" are
143 trials for "All" genders and 2 trials for "Male" genders.
Clinical Trials Status at Arnold Palmer Hospital for Children
Currently, there are 103 active trials in "Arnold Palmer Hospital for Children".
1 are not yet recruiting,
49 are recruiting,
50 are Active, not recruiting,
and 3 are Enrolling by invitation.
In total, there were 30 completed trials in Arnold Palmer Hospital for Children,
2 suspended trials,
and 7 terminated clinical trials to date.
Out of the total trials that were conducted in Arnold Palmer Hospital for Children, 14 "Phase 1"
clinical trials were conducted, 53 "Phase 2" clinical
trials and 55 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 12 trials that are defined as “Not Applicable".